Early High-Dose Vitamin D3 for Critically Ill, Vitamin D–Deficient Patients | NEJM
Original Article from The New England Journal of Medicine — Early High-Dose Vitamin D3 for Critically Ill, Vitamin D–Deficient Patients
Related Articles
Statement from Monica M. Bertagnolli, M.D., on ending her tenure as
Dr. Bertagnolli served as the 17th NIH Director.
Associations between per-and polyfluoroalkyl substances (PFAS) and county-level cancer incidence between 2016 and 2021 and incident cancer burden attributable to PFAS in drinking water in the United States
Journal of Exposure Science & Environmental Epidemiology – Associations between per-and polyfluoroalkyl substances (PFAS) and county-level cancer incidence between 2016 and 2021 and incident…
High Immunoglobulin Expression Shows Long-Term Survival in Breast Cancer
Data support the IGG signature, especially its key gene subset, as a potential marker of sustained antitumor activity in breast cancer.
FDA Clears Novel Cancer Immunotherapy R-5780 for Early-Stage Trial
R-5780, an oral immuno-oncology drug designed to activate gut-regulated immune pathways, will now be evaluated in a phase 1 trial for cancer treatment.
Chemicals in sewage sludge fertilizer pose cancer risk, EPA says
Harmful chemicals in sewage sludge spread on pasture as fertilizer pose a risk to people who regularly consume milk, beef and other products from those…
Prevention and screening drive drop in cancer deaths
Most deaths avoided from common cancers between 1975 and 2020 could be traced to prevention and screening efforts.
Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials
PURPOSEOver the past 15 years, the landscape of early phase clinical trials (EPCTs) has undergone a remarkable expansion in both quantity and intricacy. The proliferation…
TRAIL agonists rescue mice from radiation-induced lung, skin or esophageal injury – PubMed
Radiotherapy can be limited by pneumonitis which is impacted by innate immunity, including pathways regulated by TRAIL death receptor DR5. We investigated whether DR5 agonists…
Wafik El-Deiry: Outstanding news of acceptance of a manuscript with translational relevance in oncology – OncoDaily
Wafik El-Deiry: Outstanding news of acceptance of a manuscript with translational relevance in oncology / cancer, OncoDaily, Oncology, Wafik El-Deiry
NCCN Joins International Meeting to Improve Cancer Care in the Middle East North Africa Region
The National Comprehensive Cancer Network (NCCN) announced that the organization participated in a 2-day meeting at the Middle East North Africa (MENA)-NCCN Regional Coordinating Center.